Lawrence J. Jasinski

Lawrence J. Jasinski (chief executive) discloses dealings in 2 companies, chiefly Lemaitre Vascular Inc and Lifeward Ltd. We count 37 filings; the first trade dates from 4 May 2021 and the latest from 26 February 2026.

On the open market, the record shows 1 purchase worth €10k and 15 sales worth €800k. Taken together, the sales exceed the purchases by €790k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants and 8 option exercises.

The latest filing, published on 2 March 2026, reports a share grant in Lemaitre Vascular Inc. The most recent open-market purchase was published on 16 March 2023, 1,312 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.